Track topics on Twitter Track topics that are important to you
MedImmune LLC granted PhaseBio Pharmaceuticals Inc. exclusive global rights to MEDI2452 (renamed PB2452), which is entering P...
Original Article: PhaseBio licenses MedImmune's ticagrelor reversal agentNEXT ARTICLE
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...